Santhera Pharmaceuticals Holding AG
Develops and commercializes medicines for rare neuromuscular and pulmonary diseases.
SANN | SW
Overview
Corporate Details
- ISIN(s):
- CH1276028821 (+1 more)
- LEI:
- 54930035HAOFTTQH0U85
- Country:
- Switzerland
- Address:
- HOHENRAINSTRASSE 24, 4133 PRATTELN
- Website:
- https://www.santhera.com/
- Sector:
- Manufacturing
Description
Santhera Pharmaceuticals is a specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare diseases. The company concentrates on therapeutic areas with high unmet medical need, particularly rare neuromuscular and pulmonary diseases. Its research and development pipeline includes treatments for mitochondrial disorders and gene therapy for conditions such as LAMA2-deficient congenital muscular dystrophy (CMD).
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Santhera Pharmaceuticals Holding AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Santhera Pharmaceuticals Holding AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Santhera Pharmaceuticals Holding AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-01-11 | N/A | Non-Executive member | Buy | None | 42,600.00 CHF |
| 2022-01-10 | N/A | Executive member | Buy | None | 14,420.00 CHF |
| 2022-01-05 | N/A | Executive member | Buy | None | 37,000.00 CHF |
Peer Companies
